Literature DB >> 8589158

Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases.

J P Ross1, S M Holland, V J Gill, E S DeCarlo, J I Gallin.   

Abstract

Chronic granulomatous disease (CGD) is characterized by a defect in phagocytic cells that leads to recurrent superficial and deep pyogenic infections. Burkholderia (Pseudomonas) gladioli is a gram-negative bacillus in the pseudomallei group of pseudomonads that is known primarily as a plant pathogen. We report two cases of pneumonia, one accompanied by septicemia, caused by B. gladioli in patients with CGD and their successful treatment with antibiotics. We believe these represent the first reports of human disease caused by this organism. We conclude that B. gladioli should be considered a potential pathogen in patients with CGD.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8589158     DOI： 10.1093/clinids/21.5.1291

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  23 in total

1.  Abnormal technetium labelled white cell scan in the colitis of chronic granulomatous disease.

Authors:  S Hoare; J E Walsh; E Eastham; M A Abinun; A J Cant
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

2.  Burkholderia gladioli sepsis in newborns.

Authors:  Arzu Dursun; Aysegul Zenciroglu; Belma Saygili Karagol; Nilay Hakan; Nurullah Okumus; Nese Gol; Gonul Tanir
Journal:  Eur J Pediatr       Date:  2012-05-31       Impact factor: 3.183

Review 3.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

4.  Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies.

Authors:  Bich-Thuy T Sim; Sarah K Browne; Marguerite Vigliani; Dalila Zachary; Lindsey Rosen; Steven M Holland; Steven M Opal
Journal:  J Clin Immunol       Date:  2013-05-26       Impact factor: 8.317

5.  Species-specific PCR as a tool for the identification of Burkholderia gladioli.

Authors:  P W Whitby; L C Pope; K B Carter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Burkholderia gladioli infection isolated from the blood cultures of newborns in the neonatal intensive care unit.

Authors:  F Zhou; H Ning; F Chen; W Wu; A Chen; J Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-30       Impact factor: 3.267

7.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

8.  Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.

Authors:  David E Greenberg; Stephen F Porcella; Adrian M Zelazny; Kimmo Virtaneva; Dan E Sturdevant; John J Kupko; Kent D Barbian; Amenah Babar; David W Dorward; Steven M Holland
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

9.  Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 10.  Chronic granulomatous disease.

Authors:  Steven M Holland
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-22       Impact factor: 3.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.